NCT05176197 is a NA clinical trial of Almond in Glucose Intolerance, sponsored by Purdue University.

Who is sponsoring NCT05176197?

NCT05176197 is sponsored by Purdue University.

What drugs are being tested in NCT05176197?

Interventions in NCT05176197: Almond, Control.

What condition does NCT05176197 study?

NCT05176197 studies Glucose Intolerance, Glucose Metabolism Disorders (Including Diabetes Mellitus).

Is NCT05176197 still recruiting?

NCT05176197 is currently status unknown. Last updated 12 December 2023.

Last reviewed 2023-12-12 · How we verify

NCT05176197

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Almonds on Glycemia in Adults With Elevated Hemoglobin A1c Concentrations

Status unknown NA Last updated 12 December 2023

What this trial tests

NA trial testing Almond in Glucose Intolerance in 84 participants. Status unknown.

Timeline

9 February 2022

Primary endpoint
30 July 2023

30 May 2024

Quick facts

Lead sponsor	Purdue University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	basic science
Enrollment	84
Start date	9 February 2022
Primary completion	30 July 2023
Estimated completion	30 May 2024
Sites	1 location across United States

Drugs / interventions tested

Almond
Control

Conditions studied

Glucose Intolerance — all drugs for Glucose Intolerance →
Glucose Metabolism Disorders (Including Diabetes Mellitus) — all drugs for Glucose Metabolism Disorders (Including Diabetes Mellitus) →

Sponsor

Purdue University

Who can join

Adults 18 to 70, any sex, with Glucose Intolerance or Glucose Metabolism Disorders (Including Diabetes Mellitus). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will examine the effects of regular almond consumption by individuals with elevated HbA1c on long-term glycemic control.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effects of daily almond consumption on glycaemia in adults with elevated risk for diabetes: a randomised controlled trial.
Huang LC, Henderson GC, Mattes RD. · · 2024 · cited 1× · PMID 39431574 · DOI 10.1017/s0007114524001053

Verify or expand the search:

Other trials of Almond

Trials testing the same drug.

NCT06363409 — The Acute and Accumulative Effects of Snack Foods on Exercise Recovery · NA · recruiting
NCT05322304 — Almonds and Cognitive Functions · NA · unknown
NCT05059639 — Exploring the Role of Almonds in Enhancing Immune Strength · NA · completed
NCT04787718 — Almond for Physical Performance · NA · completed
NCT04352504 — The Effect of a Healthy Snack on Radiance, Aging and Inflammation of the Skin · NA · completed

Other recruiting trials for Glucose Intolerance

Currently open trials in the same condition.

NCT06920641 — Effects of Tagatose on Glycemic Response and Gastrointestinal Microbiota in Healthy Adults · NA · recruiting
NCT06684106 — Ursodeoxycholic Acid Attenuates Statin-Induced Impaired Glucose Tolerance · NA · recruiting
NCT05775627 — Sleep and Metabolism · NA · recruiting
NCT06366399 — The Acute T-Rex (Timing of Resistance Exercise) Study · NA · recruiting
NCT05874635 — Signos DM2 Empowerment Study (SIGNOS-CGM-EMPOWER-201-2022) · NA · active not recruiting

Other Purdue University trials

Trials by the same sponsor.

NCT07287774 — Evaluating a Deep Neural Noise-Reduction Algorithm for Hearing Aids · NA · recruiting
NCT07086833 — The Food Environment, Microbial Cysteine Metabolism, and Cancer Disparities · NA · recruiting
NCT06638944 — Wearable Biofeedback for Swallowing Disorders Rehabilitation in Stroke and Parkinson Disease · Phase 2 · recruiting
NCT07048392 — Retrieval-Based Word Learning in Developmental Language Disorder During Book Reading II · NA · recruiting
NCT06258941 — Classroom Break, Cognition, and Fitness in Elementary School Children · Phase 1, PHASE2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05176197 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Purdue University
Last refreshed: 12 December 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05176197.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing